These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

583 related articles for article (PubMed ID: 16567956)

  • 41. Extended beta-globin locus control region elements promote consistent therapeutic expression of a gamma-globin lentiviral vector in murine beta-thalassemia.
    Hanawa H; Hargrove PW; Kepes S; Srivastava DK; Nienhuis AW; Persons DA
    Blood; 2004 Oct; 104(8):2281-90. PubMed ID: 15198957
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hematopoietic stem cell mobilization strategies for gene therapy of beta thalassemia and sickle cell disease.
    Yannaki E; Stamatoyannopoulos G
    Ann N Y Acad Sci; 2010 Aug; 1202():59-63. PubMed ID: 20712773
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gene Therapy of the β-Hemoglobinopathies by Lentiviral Transfer of the β(A(T87Q))-Globin Gene.
    Negre O; Eggimann AV; Beuzard Y; Ribeil JA; Bourget P; Borwornpinyo S; Hongeng S; Hacein-Bey S; Cavazzana M; Leboulch P; Payen E
    Hum Gene Ther; 2016 Feb; 27(2):148-65. PubMed ID: 26886832
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genetic strategies for the treatment of sickle cell anaemia.
    Mansilla-Soto J; Rivière I; Sadelain M
    Br J Haematol; 2011 Sep; 154(6):715-27. PubMed ID: 21707580
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Engraftment of immune-deficient mice with primitive hematopoietic cells from beta-thalassemia and sickle cell anemia patients: implications for evaluating human gene therapy protocols.
    Larochelle A; Vormoor J; Lapidot T; Sher G; Furukawa T; Li Q; Shultz LD; Olivieri NF; Stamatoyannopoulos G; Dick JE
    Hum Mol Genet; 1995 Feb; 4(2):163-72. PubMed ID: 7757063
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hemoglobin disorders: lentiviral gene therapy in the starting blocks to enter clinical practice.
    Sii-Felice K; Giorgi M; Leboulch P; Payen E
    Exp Hematol; 2018 Aug; 64():12-32. PubMed ID: 29807062
    [TBL] [Abstract][Full Text] [Related]  

  • 47. siRNA-mediated reduction of alpha-globin results in phenotypic improvements in beta-thalassemic cells.
    Voon HP; Wardan H; Vadolas J
    Haematologica; 2008 Aug; 93(8):1238-42. PubMed ID: 18556409
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Beta-thalassemia and sickle cell disease in culture of early erythroid precursors: hemoglobin synthesis and ultrastructural study.
    Beuzard Y; Tulliez M; Testa U; Vainchenker W; Dubart A; Tsapis A; Galacteros F; Breton-Gorius J; Rosa J
    Blood Cells; 1981; 7(1):179-200. PubMed ID: 7187747
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anti-beta s-ribozyme reduces beta s mRNA levels in transgenic mice: potential application to the gene therapy of sickle cell anemia.
    Alami R; Gilman JG; Feng YQ; Marmorato A; Rochlin I; Suzuka SM; Fabry ME; Nagel RL; Bouhassira EE
    Blood Cells Mol Dis; 1999 Apr; 25(2):110-9. PubMed ID: 10389593
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hemoglobin switching and its clinical implications.
    Blau CA; Stamatoyannopoulos G
    Curr Opin Hematol; 1994 Mar; 1(2):136-42. PubMed ID: 9371272
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Towards gene therapy of hemoglobinopathies.
    Beuzard Y
    Semin Hematol; 1996 Jan; 33(1):43-52. PubMed ID: 8714584
    [No Abstract]   [Full Text] [Related]  

  • 52. Gene Therapy for beta-thalassemia.
    Malik P; Arumugam PI
    Hematology Am Soc Hematol Educ Program; 2005; ():45-50. PubMed ID: 16304358
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Parallel assessment of globin lentiviral transfer in induced pluripotent stem cells and adult hematopoietic stem cells derived from the same transplanted β-thalassemia patient.
    Tubsuwan A; Abed S; Deichmann A; Kardel MD; Bartholomä C; Cheung A; Negre O; Kadri Z; Fucharoen S; von Kalle C; Payen E; Chrétien S; Schmidt M; Eaves CJ; Leboulch P; Maouche-Chrétien L
    Stem Cells; 2013 Sep; 31(9):1785-94. PubMed ID: 23712774
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hematopoietic stem cell gene transfer for the treatment of hemoglobin disorders.
    Persons DA
    Hematology Am Soc Hematol Educ Program; 2009; ():690-7. PubMed ID: 20008255
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gene Therapy Approaches to Hemoglobinopathies.
    Ferrari G; Cavazzana M; Mavilio F
    Hematol Oncol Clin North Am; 2017 Oct; 31(5):835-852. PubMed ID: 28895851
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The degree of phenotypic correction of murine beta -thalassemia intermedia following lentiviral-mediated transfer of a human gamma-globin gene is influenced by chromosomal position effects and vector copy number.
    Persons DA; Hargrove PW; Allay ER; Hanawa H; Nienhuis AW
    Blood; 2003 Mar; 101(6):2175-83. PubMed ID: 12411297
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetic defects in the thalassemias.
    Bank A
    Curr Top Hematol; 1985; 5():1-23. PubMed ID: 3882340
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gene Therapy for β-Hemoglobinopathies: From Discovery to Clinical Trials.
    Segura EER; Ayoub PG; Hart KL; Kohn DB
    Viruses; 2023 Mar; 15(3):. PubMed ID: 36992422
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gene therapy for β-thalassaemia: the continuing challenge.
    Yannaki E; Emery DW; Stamatoyannopoulos G
    Expert Rev Mol Med; 2010 Oct; 12():e31. PubMed ID: 20883576
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular biology of hemoglobin: its application to sickle cell anemia and thalassemia.
    Kan YW
    Schweiz Med Wochenschr Suppl; 1991; 43():51-4. PubMed ID: 1726857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.